CNB-001 a Novel Curcumin Derivative, Guards Dopamine Neurons in MPTP Model of Parkinson’s Disease

Figure 3

Open field test of control and experimental mice. MPTP injection resulted in significant decrease in central and peripheral movements and grooming and rearing activities when compared to control. However, these motor impairments were reduced when pretreated with CNB-001. Values are expressed as mean ± SD for six animals in each group. ^∗𝑃<0.05 compared to control, ^#𝑃<0.05 compared to MPTP.

(a)

(b)

(c)

(d)